Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UBROGEPANT for Migraine prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where UBROGEPANT was used for Migraine prophylaxis.

Most Reported Side Effects for UBROGEPANT

Side Effect Reports % Deaths Hosp.
Drug ineffective 656 25.9% 1 10
Migraine 399 15.8% 1 41
Nausea 210 8.3% 0 7
Headache 204 8.1% 0 20
Off label use 132 5.2% 2 4
Dizziness 111 4.4% 1 6
Fatigue 92 3.6% 0 8
Somnolence 87 3.4% 0 2
Therapeutic product effect incomplete 69 2.7% 0 2
Vomiting 67 2.7% 0 6
Pain 61 2.4% 0 13
Therapeutic response decreased 57 2.3% 0 0
Feeling abnormal 53 2.1% 0 2
Wrong technique in product usage process 47 1.9% 0 0
Maternal exposure during pregnancy 44 1.7% 0 3

Other Indications for UBROGEPANT

Migraine (1,318) Product used for unknown indication (1,008) Headache (113) Migraine with aura (20) Migraine without aura (14) Maternal exposure timing unspecified (9) Cluster headache (5)

Other Drugs Used for Migraine prophylaxis

ERENUMAB-AOOE (9,326) TOPIRAMATE (1,227) GALCANEZUMAB-GNLM (1,066) RIMEGEPANT (524) FREMANEZUMAB-VFRM (461) EPTINEZUMAB-JJMR (263) PROPRANOLOL (194) AMITRIPTYLINE (185) ATOGEPANT (177) ONABOTULINUMTOXINA (159)

Related Pages

UBROGEPANT Full Profile All Migraine prophylaxis Drugs UBROGEPANT Demographics UBROGEPANT Timeline